PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 268 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $310,000 | -8.8% | 5,829 | 0.0% | 0.03% | -3.7% |
| Q2 2022 | $340,000 | -0.9% | 5,829 | +29.8% | 0.03% | +22.7% |
| Q1 2022 | $343,000 | +29.9% | 4,490 | +2.4% | 0.02% | +57.1% |
| Q4 2021 | $264,000 | +20.5% | 4,383 | +12.3% | 0.01% | +7.7% |
| Q3 2021 | $219,000 | +2.8% | 3,904 | +11.1% | 0.01% | 0.0% |
| Q2 2021 | $213,000 | -25.3% | 3,513 | -13.7% | 0.01% | -31.6% |
| Q1 2021 | $285,000 | – | 4,070 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |